Liraglutide in Adults with Type 2 Diabetes: Global Perspective on Safety, Efficacy and Patient Preference

Incretin-based therapies have been gaining much attention recently as a new class of therapeutics for type 2 diabetes worldwide. Among them, glucagon-like peptide-1 receptor agonist liraglutide has been rapidly increasing its global usage. Once daily injection of liraglutide significantly ameliorate...

Descripción completa

Detalles Bibliográficos
Autores principales: Yabe, Daisuke, Seino, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411533/
https://www.ncbi.nlm.nih.gov/pubmed/22879794
http://dx.doi.org/10.4137/CMED.S5976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411533/
https://www.ncbi.nlm.nih.gov/pubmed/22879794
http://dx.doi.org/10.4137/CMED.S5976

Ejemplares similares